142 results on '"Matano, E."'
Search Results
2. Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer
3. Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer
4. In-vitro-, In-vivo- und Phase-I-Studien zu Oxaliplatin und Topotecan in Kombination bei humanen Karzinomen: 2461
5. Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in patients with non-small cell lung cancer <= 3 cm in size
6. P1.17-015 Long Acting Octreotide plus Prednisone in Advanced Thymic Epithelial Tumors: A Real Life Clinical Experience
7. Triplets versus doublets with or without cisplatin in the first-line treatment of stage IIIB-IV nonsmall cell lung cancer (NSCLC) patients: Preliminary results of a multicenter randomized factorial study
8. Carcinoma del polmone
9. Melanoma
10. Altre Neoplasie
11. Somatostatin Analogs as mainteinance therapy in heavily pretreated thymic epithelial tumors
12. Effectiveness of somatostatin analogs plus prednisone in aggressive histotype and advanced stage of thymic epithelial tumors
13. Correlation between plasmatic levels of vitamin D and testicular cancer
14. Tumori Urologici: Prostata, Rene e Vescica
15. Altre Neoplasie
16. Melanoma
17. Mitoxantrone, Etoposide and bleomycin (meb) chemotherapy innon-hodgkins-lymphoma patients non-elegible for standard cyclophosphamide,Doxorubicin, vincristine and prednisone (chop) combination
18. Cardiovascular monitoring of drug-resistant lymphomapatients treated with epoch chemotherapy plus high-dose verapamil in continuous-infusion
19. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FLFOX-4) as first-line treatment of advanced gastric cancer patients
20. Tumor del rene, della Vescica e della Prostata
21. Altre Neoplasie
22. Phase I clinical trial of high dose recombinant interleukin-2/veparimil combination in advancer cancer
23. Manuale di Oncologia Clinica
24. VEGF and VEGF Receptors in Thymic Epithelial Tumors (Tet): Pathological Features and Clinical Implications
25. Mitoxantrone, etoposide and bleomycin (MEB) chemotherapy in non-Hodgkin's Lymphoma patients non-elegible for standard cyclophosphamide, doxorubicin vincristine and prednisone (CHOP) combination
26. H30 - Somatostatin Analogs as mainteinance therapy in heavily pretreated thymic epithelial tumors
27. H21 - Effectiveness of somatostatin analogs plus prednisone in aggressive histotype and advanced stage of thymic epithelial tumors
28. F19 - Correlation between plasmatic levels of vitamin D and testicular cancer
29. Paraneoplastic Sensitive Neuropathy Associated with Anti-Hu Antibodies in a Neuroendocrine Tumor of Duodenum: A Case Report
30. Clinical outcome of patients with thymic epithelial tumors
31. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients
32. Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study
33. Tailored therapy for aggressive non-Hodgkin's lymphoma: results of a phase II study with a long-term follow-up.
34. High-dose recombinant interleukin-2/verapamil combination in advanced cancer
35. alpha-Interferon potentiates the growth inhibitory effects of anti-transferrin receptor monoclonal antibodies
36. MITOXANTRONE, ETOPOSIDE AND BLEOMYCIN (MEB) CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA PATIENTS NON-ELEGIBLE FOR STANDARD CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) COMBINATION
37. Chlorambucil, Vincristine and Cytarabine (COA) Treatment of Low Grade Lymphomas
38. CARDIOVASCULAR MONITORING OF DRUG-RESISTANT LYMPHOMA PATIENTS TREATED WITH EPOCH CHEMOTHERAPY PLUS HIGH-DOSE VERAPAMIL IN CONTINUOUS-INFUSION
39. Low-dose dopamine induces early recovery of recombinant interleukin-2—Impaired renal function
40. Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).
41. Imatinib mesylate in thymic epithelial malignancies.
42. 1687 - VEGF and VEGF Receptors in Thymic Epithelial Tumors (Tet): Pathological Features and Clinical Implications
43. Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer
44. CA 15-3 in Human Breast Cancer.: Comparison with Tissue Polypeptide Antigen (TPA) and Carcinoembryonic Antigen (CEA)
45. High number of circulating CD34(+) cells in patients with myelophthisis
46. Cardiovascular monitoring of drug-resistant lymphoma patients treated with EPOCH chemotherapy plus high dose verapamil in continuous infusion
47. 18F-FDG-PET/CT and 111In-Octreotide SPECT in the Evaluation of Patients with Neuroendocrine Lung Tumors
48. Sunitinib in a MEN-1 Patient with Small Cell Neuroendocrine Tumor of the Thymus.
49. Impact of a cardio‐oncology unit on prevention of cardiovascular events in cancer patients
50. Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.